Tag: sars-cov-2
Sinovac coronavirus vaccine “significantly less effective than what previous data suggested”
The São Paulo-based Butantan Institute – which is running final-stage clinical trials for CoronaVac, manufactured by Beijing-based Sinovac – submitted new data to Brazil’s health regulator on Tuesday, listing an efficacy rate of 50.4 per cent. More...
Spike E484K mutation in the first SARS-CoV-2 reinfection case confirmed in Brazil
On December 9th [2020], the Brazilian Ministry of Health (MoH) recognised the first case of reinfection in the country. More...
Gorillas test positive for coronavirus at San Diego park
“Several gorillas at the San Diego Zoo Safari Park have tested positive for the coronavirus in what is believed to be the first known cases among such primates in the United States and possibly the world. More...
Chinese study finds most patients still show signs of ‘long Covid’ six months later
The largest study of its kind found that most of those treated in a Wuhan hospital were still showing symptoms six months after being sent home
The most common problems were fatigue and difficulty in sleeping, but lung and kidney problems were also recorded
Another new variant of the novel coronavirus has been found in Japan
The new mutant strain, which is partly similar to different variants reported in the U.K. More...
Animal Coronaviruses and SARS-CoV-2 in animals – a summary of what we know
“..SARS-CoV-2 is demonstrating the ability to infect and sometime cause respiratory distress in many mammalian species. More...
Emergence of Y453F and Δ69-70HV mutations in a lymphoma patient with long-term COVID-19
“We report a genomic analysis of SARS-CoV-2 from a lymphoma patient with long-term COVID-19. More...
Long Covid Study: 6-month consequences of COVID-19 in patients discharged from hospital
The long-term health consequences of COVID-19 remain largely unclear. More...
CDC: allergic reactions including anaphylaxis after receipt of the first dose of Pfizer BioNTech COVID-19 vaccine
During December 14–23, 2020, monitoring by the Vaccine Adverse Event Reporting System detected 21 cases of anaphylaxis after administration of a reported 1,893,360 first doses of the Pfizer-BioNTech COVID-19 vaccine (11.1 cases per million doses); 71% of these occurred within 15 minutes of vaccination
https://www.cdc.gov/mmwr/volumes/70/wr/mm7002e1.htm?s_cid=mm7002e1_w More...
Cornwall: near 500% rise in cases of Covid-19 in children aged 0-4yrs over Xmas
A week on week comparison of the rates of infection per hundred thousand reveal that some of the largest increases in percentages in the week from December 24 (Christmas Eve) to December 31 (New Year’s Eve) are in children under four years old (increase of 485.7%), those aged 70 to 74 (367.2%) and 85 to 89 (433.3%). More...